/PRNewswire/ –Co-Diagnostics, Inc. (Nasdaq: CODX)(“Co-Dx” or “the Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today…
/PRNewswire/ –Co-Diagnostics, Inc. (Nasdaq: CODX)(“Co-Dx” or “the Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today…